Essity Strategy and Business Model

Executive Overview

Essity is a Sweden-based hygiene and health company whose portfolio spans adult incontinence, baby care, feminine care, consumer tissue, professional hygiene, wound care, compression therapy, and orthopedics. Headquartered in Stockholm and listed on Nasdaq Stockholm, Essity became an independent company in 2017 through the spin-off of SCA’s hygiene business, although many of its brands, factories, and category positions were built over decades before that separation. In FY2024, Essity generated more than SEK 140 billion of net sales. The company operates in roughly 150 countries, with Europe and North America its largest regions and additional scale in Latin America and selected Asian markets.

Strategically, Essity is not just a tissue producer or a maker of absorbent products. Its model is to compete in categories where repeat consumption, trusted brands, product performance, distribution reach, and manufacturing know-how can support resilient demand and better margins. That logic helps explain why Health & Medical and Professional Hygiene are strategically important, why adult incontinence remains a major growth theme, and why portfolio moves such as the 2024 disposal of Essity’s majority stake in Vinda matter. For a smart reader, the key to understanding Essity is understanding how it turns everyday hygiene and care needs into repeat-driven, increasingly higher-value solutions.

Essity at a Glance

Logo
Common name	Essity
Full legal name	Essity Aktiebolag (publ)
Headquarters	Stockholm, Sweden
Ownership	Public company; dual-class share structure with Class A and Class B shares
Ticker	ESSITY B
Exchange	STO - Nasdaq Stockholm
Market Cap	#N/A
Revenue (FY2024)	$145.55B
Founding / major historical milestones	Independent since 2017 after spin-off from SCA; roots in hygiene businesses developed over many decades inside SCA
Industry or industries	Hygiene products, tissue, personal care, professional hygiene, health and medical solutions
Key products or services	Adult incontinence products, baby diapers, feminine care, consumer tissue, professional hygiene dispensers and consumables, wound care, compression therapy, orthopedics
Geographic footprint	Sales in roughly 150 countries; manufacturing and commercial operations across Europe, North America, Latin America, and selected Asian markets
Business segments as officially reported	Health & Medical; Consumer Goods; Professional Hygiene
Company website	https://www.essity.com

1. What Is the Strategy of Essity?

1. 1a. What is the winning aspiration of Essity?

   Essity’s public purpose is often framed around breaking barriers to well-being. In practical strategy terms, that means being a leading global hygiene and health company, not merely a low-cost paper converter. Winning for Essity appears to mean growing profitably in categories where hygiene, health outcomes, convenience, and brand trust matter, while steadily improving the portfolio mix toward segments with better structural economics.

   Based on FY2024 reporting and investor communication, management’s aspiration is not just volume growth. It is profitable growth, stronger category positions, and better resilience through a combination of innovation, brand investment, productivity, and portfolio choices. The 2024 sale of the majority stake in Vinda fits that aspiration because it points capital away from lower-priority exposures and toward higher-return uses.

2. 1b. Where does Essity play?

   Essity chooses to play in hygiene and health categories with large, repeat-driven demand: adult incontinence, baby care, feminine care, consumer tissue, professional hygiene, wound care, compression therapy, and orthopedics. It serves both consumer and institutional markets, which is strategically important because these markets have different demand cycles and different pricing mechanisms.

   Geographically, Essity plays broadly rather than narrowly, with strong positions in Europe, North America, and Latin America, plus selected exposure to Asia. Channel-wise, it participates through retail, e-commerce, pharmacies, healthcare procurement, distributors, and business-to-business hygiene channels. This is a deliberately diversified competitive field, but still narrower than “all paper and hygiene products.” Essity tends to focus where brand, product efficacy, clinical credibility, or system solutions can matter more than commodity price alone.

3. 1c. How does Essity plan to win?

   Essity’s recipe for winning is a blend of differentiation and scaled operational discipline. In Consumer Goods, it tries to win through brand strength, product performance, innovation, and shelf presence. In Professional Hygiene, it increasingly competes as a solution provider, using dispenser systems, service concepts, and data-enabled cleaning workflows to make the offer more than a roll of tissue or a soap refill. In Health & Medical, it competes through clinically relevant products, trusted brands, and channel access into hospitals, long-term care, home care, and pharmacies.

   The economic logic is clear: categories with more technical performance, stronger brands, or embedded replenishment behavior generally offer better pricing power and more stable margins than undifferentiated tissue. Essity therefore appears to be trying to win by shifting the mix toward higher-value categories while still using scale procurement, manufacturing, and global route-to-market as core advantages.

4. 1d. What capabilities must Essity have in place?

   To execute that strategy, Essity needs a specific set of capabilities. First, it needs materials and product-development expertise in absorbency, skin health, wound care, compression, tissue softness and strength, and dispenser systems. Second, it needs large-scale manufacturing and converting excellence across pulp-based tissue and absorbent hygiene products. Third, it needs procurement strength in fiber, pulp, superabsorbent polymers, nonwovens, packaging, and energy.

   It also needs commercial capabilities that vary by segment: retailer negotiation and trade execution in consumer products; distributor and key-account management in professional hygiene; and clinical, reimbursement, and regulatory know-how in health and medical. Finally, it needs portfolio management discipline, because where capital is allocated matters as much as how factories are run.

5. 1e. What management systems does Essity require?

   Essity needs management systems that connect brand building with manufacturing economics. That includes pricing and revenue growth management, procurement and productivity programs, rigorous quality systems, regulatory compliance for medical products, and capital-allocation discipline across categories and geographies.

   At a practical level, the company also needs strong category-level and segment-level performance management: tracking volumes, pricing, mix, raw-material exposure, plant efficiency, channel performance, and working capital. Sustainability metrics are increasingly part of the management system as well, because fiber sourcing, packaging, energy use, and emissions affect both cost and customer preference. In other words, Essity’s strategy depends on a system that can manage both consumer-brand metrics and industrial operating metrics at the same time.

2. What Are the Current Strategic Initiatives of Essity?

Based on FY2024 disclosures and related investor communications, Essity’s current strategic initiatives are concrete rather than abstract.

• Reshaping the portfolio toward higher-return categories. The most visible move was the 2024 disposal of Essity’s majority stake in Vinda. Strategically, that reduced exposure to a more complex, lower-priority ownership position and supported a sharper focus on categories and geographies where Essity believes it can earn better returns.
• Restoring and improving profitability after raw-material inflation. Essity spent the last several years pushing through price increases, improving mix, and driving cost productivity to recover margins after sharp inflation in pulp, energy, and other inputs. That effort remains a live initiative because it is about structural efficiency, not just one round of price hikes.
• Expanding Health & Medical. Essity continues to prioritize wound care, compression therapy, orthopedics, and incontinence care sold into healthcare settings. This segment offers stronger clinical differentiation and, in many cases, better economics than mature consumer tissue.
• Building faster-growing personal care adjacencies. Adult incontinence remains one of Essity’s most important long-term growth themes, supported by aging demographics and rising awareness. The company has also moved into leakproof apparel and related categories through acquisitions such as Knix, which broaden its reach into younger consumers and direct-to-consumer channels.
• Developing Professional Hygiene as a systems business. Under the Tork brand, Essity has been pushing beyond consumables into dispenser platforms, workflow support, hygiene education, and digital/connected solutions. The strategic aim is to deepen customer relationships and make the business less commodity-like.
• Embedding sustainability into product design and operations. Public materials consistently highlight lower environmental impact, responsible sourcing, packaging improvements, and reduced emissions. For Essity, sustainability is both a compliance issue and a route to brand preference, customer qualification, and cost efficiency.

3. What Is the Business Model of Essity?

What customers actually buy

Customers buy repeat-use hygiene and health products that solve everyday care, cleaning, and medical needs. In retail, that means diapers, pads, tissue, and feminine care. In healthcare, it means wound dressings, compression products, braces, and incontinence solutions. In professional hygiene, customers buy dispensers plus a recurring stream of refills and related consumables.

Recurring versus one-time revenue

Most of Essity’s revenue is repeat-driven rather than one-time. Tissue, incontinence, feminine care, baby care, and medical consumables are replenishment categories by definition. Professional Hygiene has especially attractive repeat characteristics because a dispenser installation can anchor ongoing refill demand. Essity does have some less-recurring revenue in dispensers and certain orthopedic or medical products, but the company is fundamentally built around frequent replenishment.

How pricing power works

Essity has some pricing power, but it is not unlimited. It tends to be stronger where the company has leading brands, product-performance advantages, clinical credibility, or a dispenser-and-refill ecosystem. Pricing power is weaker where products are closer to commodities or where retailer own-label offerings are strong. In practice, pricing is often a mix of annual negotiations, channel-specific list pricing, promotional/trade-spend decisions, and, in healthcare, tender or reimbursement dynamics.

Why the business mix matters

Business mix is central to Essity’s economics. Consumer tissue is large and cash-generative but can be more exposed to commodity swings and private-label pressure. Health & Medical and Professional Hygiene generally have better differentiation, more technical selling, and often better margin potential. That is why portfolio reshaping matters so much strategically: not all hygiene revenue is equally valuable.

What drives gross margin, operating margin, and cash generation

Gross margin is driven mainly by fiber and pulp costs, superabsorbent polymer and nonwoven costs, energy, logistics, plant efficiency, and product mix. Operating margin depends on gross margin plus the cost of brand support, sales coverage, clinical and regulatory overhead, and distribution complexity. Cash generation is supported by the repeat nature of demand, but it is also shaped by inventory levels, receivables, capital expenditure, and the timing of raw-material cycles.

Essity is therefore neither a pure subscription model nor a simple commodity producer. It is best understood as a repeat-consumption manufacturing company with selected ecosystem economics, especially in professional hygiene and certain medical categories.

4. What Products and Services Does Essity Sell?

Health & Medical

This segment includes wound care, compression therapy, orthopedics, and incontinence products sold into healthcare channels. Brands associated with this segment include Leukoplast, Cutimed, JOBST, and Actimove. Strategically, this is one of Essity’s most important businesses because it combines repeat demand with more clinical differentiation and usually less direct exposure to private-label tissue-style competition.

Consumer Goods

Consumer Goods includes adult incontinence sold through retail channels, baby care, feminine care, and consumer tissue. TENA is central in adult incontinence. Libero is a key baby care brand in parts of Europe. Libresse, Bodyform, Nosotras, and Saba are important feminine care brands in different geographies. Tempo and Zewa are prominent tissue brands in Europe. Consumer Goods likely remains Essity’s largest revenue pool, but within that segment the growth and profit profile varies materially by category.

Professional Hygiene

This business is built primarily around the Tork brand. It offers dispensers, tissue, hand towels, soap, napkins, and related hygiene solutions for workplaces, hospitality, healthcare settings, education, and public facilities. Strategically, Tork is important because it is not just a product line; it is a solution platform with channel depth, installed equipment, and repeat refill demand.

Which offerings appear most important

As an external synthesis based on Essity’s segment structure and public strategy, the most strategically important offerings appear to be adult incontinence, health and medical solutions, and Tork professional hygiene. Consumer tissue remains significant in scale and cash generation, but the company’s long-run strategic emphasis appears more tilted toward categories with stronger differentiation and better margin potential.

Legacy versus newer growth offerings

Mature categories include much of consumer tissue and some traditional personal care lines. Newer or higher-priority growth areas include medical solutions, branded adult incontinence, data-enabled professional hygiene offerings, and newer leakproof apparel and direct-to-consumer propositions developed through acquisitions.

5. What Are the Key Competitors or Peers of Essity?

Competition varies sharply by segment. Essity does not face one identical rival across everything it sells. Instead, its competitive set changes across consumer tissue, personal care, professional hygiene, and medical solutions.

Private-label products are also a meaningful source of competition, especially in tissue and some absorbent hygiene categories. In several markets, Essity must compete not only with branded multinationals but also with retailer-owned brands, regional specialists, and tender-driven healthcare purchasing.

6. What Is the Marketing Strategy of Essity?

Essity’s marketing strategy differs by segment, which is exactly what one would expect from a company selling both consumer brands and medically oriented products.

In Consumer Goods, marketing relies heavily on brand building, category management, packaging, in-store execution, product claims, and digital/e-commerce support. The objective is to sustain preference and justify pricing in categories where retailers always have alternatives. Awareness, trust, and product performance matter, particularly in intimate categories such as incontinence and feminine care where stigma and habit can shape purchase behavior.

In Professional Hygiene, the emphasis is more on channel marketing, distributor enablement, workplace hygiene education, and value communication to facility managers and procurement teams. Tork’s marketing is less about broad consumer advertising and more about demonstrating hygiene outcomes, labor efficiency, dispenser uptime, and total-cost-of-use.

In Health & Medical, marketing is often closer to clinical education than classic brand advertising. Product evidence, healthcare professional trust, reimbursement knowledge, and tender support matter. In that sense, marketing is a supporting capability in medical solutions and a more direct differentiator in consumer categories.

7. What Are the Key Customer Segments of Essity?

Essity serves a diversified set of customers across consumer, institutional, and healthcare channels.

This customer base is strategically attractive because it is diversified across end markets. Essity is not dependent on one single buyer type. However, within particular categories, customer concentration can still be high because large retailers and large distributors have substantial negotiating power.

8. What Is the Sales Model of Essity?

Essity uses a multi-channel sales model aligned to each business segment.

• Consumer Goods: Sold mainly through large retailers, grocery chains, pharmacies, wholesalers, and e-commerce platforms. In some categories and brands, direct-to-consumer capability is becoming more relevant, especially after acquisitions such as Knix.
• Professional Hygiene: Sold primarily through distributors, resellers, and selected direct/key-account relationships. The channel structure matters because distributors influence product mix, customer reach, and the economics of dispenser placement and refill replenishment.
• Health & Medical: Sold through healthcare distributors, hospitals, clinics, tenders, pharmacies, and specialized sales teams. This is a more technical and relationship-driven sales process than supermarket shelf competition.

The channel structure affects growth and pricing in important ways. Retail gives scale but creates pressure on promotions and trade terms. Distributor-led channels extend reach but can reduce direct customer intimacy unless supported well. Healthcare channels often require stronger product training, reimbursement knowledge, and tender discipline. For consultants, this mix creates opportunities in distributor strategy, key-account design, salesforce effectiveness, and pricing governance.

9. In What Geographies Does Essity Operate?

Essity sells into roughly 150 countries and operates a broad manufacturing and commercial footprint. Europe remains the company’s historical center of gravity, with significant positions in the Nordic region, Germany, the United Kingdom, Spain, Italy, France, the Netherlands, Poland, and other European markets. North America is also strategically important, especially for Tork and parts of Health & Medical. Latin America matters through both manufacturing and strong local category positions in markets such as Mexico and Colombia.

Operationally, Essity has plants, converting sites, warehouses, offices, and sales organizations spread across Europe, the Americas, and selected Asian markets. In practical terms, its industrial footprint needs to balance bulky tissue logistics, hygiene-product proximity, local customer requirements, and regional sourcing economics.

As of 2024, Essity’s geographic exposure changed somewhat with the sale of its majority stake in Vinda, which reduced the importance of that ownership structure in Greater China. Even after that move, Essity remains internationally diversified, but its economic center is more concentrated in Europe and the Americas than a casual observer might assume.

10. Who Are the Owners of Essity?

Essity is a public company listed in Sweden. It has a dual-class share structure, which means voting power is more concentrated than economic ownership alone would imply. As of the FY2024 period, major shareholders publicly associated with Essity included Swedish long-term investment groups and institutions such as Industrivärden and Lundbergföretagen, along with large pension and asset-management investors. Essity does not appear to have a single 100% controlling owner, but influence is meaningfully shaped by the A/B share structure and the presence of large Swedish cornerstone shareholders.

11. How Is Essity Organized?

At a practical level, Essity is organized around three reported business segments:

• Health & Medical
• Consumer Goods
• Professional Hygiene

That reporting structure matters because these segments have different demand patterns, channels, margin profiles, and operating requirements. Consumer Goods is more retail- and brand-driven. Professional Hygiene is more distributor- and solution-driven. Health & Medical is more clinically and regulatory intensive.

Behind the segment reporting, Essity also operates through shared group functions such as procurement, manufacturing excellence, innovation, finance, sustainability, and corporate leadership. In effect, the company combines category management and brand management with a centralized industrial backbone. That hybrid structure is logical for a business that needs both local commercial adaptation and global scale benefits.

12. How Does Essity Operate?

Essity’s day-to-day operations are built around turning raw materials and product know-how into high-volume, repeat-use hygiene and medical products, then getting them to retailers, distributors, and healthcare customers reliably.

1. Sourcing. Essity buys fiber and pulp, recovered paper, superabsorbent polymers, nonwovens, films, adhesives, packaging, and energy. Commodity discipline matters because input volatility can quickly affect margins.
2. Manufacturing and converting. The company runs tissue-making and converting operations, absorbent-hygiene production lines, and more specialized medical-product manufacturing. Plant uptime, yield, energy use, quality, and labor productivity are critical value drivers.
3. Product development and quality control. Essity must continuously refine absorbency, comfort, skin-friendliness, softness, strength, fit, and clinical performance. In Health & Medical, quality and regulatory compliance are especially important.
4. Distribution and replenishment. Products flow through retailers, distributors, pharmacies, hospitals, and e-commerce channels. Because many items are bulky but relatively low value per unit of volume, freight efficiency and inventory positioning matter a great deal.
5. Commercial execution. The company manages pricing, promotions, tenders, distributor programs, dispenser placements, and category-level innovation launches. This is where strategy meets the market.

The main operational complexities are commodity swings, energy cost exposure, logistics costs, channel service levels, regulatory obligations in medical products, and the challenge of running both mature and faster-growing categories under one corporate umbrella.

13. What Are the Growth Opportunities for Essity?

• Adult incontinence. Aging populations, higher diagnosis and awareness, and consumer willingness to trade up should continue to make this one of Essity’s most plausible long-term growth engines.
• Health & Medical expansion. Wound care, compression, and related medical categories offer opportunities for innovation, channel expansion, and improved mix.
• Professional Hygiene solutions. Tork can grow not only through more consumables but also through broader solution selling, dispenser penetration, and data-enabled hygiene workflows.
• Premiumization and innovation. Higher-performance products, improved design, skin-health features, and sustainability attributes can support better pricing and mix.
• E-commerce and direct-to-consumer. Digital channels matter especially in sensitive or niche categories such as incontinence and leakproof apparel, where education and discreet purchasing can increase conversion.
• Geographic whitespace. Essity still has room to deepen positions in North America, Latin America, and selected underpenetrated segments globally.
• Targeted M&A. The company has shown that acquisitions can be used to add capabilities or enter adjacent categories, especially where the target brings brand equity, channel access, or digital capabilities.

The main constraints are retailer pricing pressure, private-label competition, procurement complexity in healthcare, raw-material volatility, foreign exchange, and the execution risk that comes with portfolio reshaping. In other words, the opportunities are real, but they depend on disciplined commercial and operating execution.

14. What Is the History of Essity?

Essity was established as an independent listed company in 2017 when Svenska Cellulosa Aktiebolaget (SCA) separated its hygiene business from its forest-products operations. Because of that origin, Essity does not have a single founder in the usual entrepreneurial sense; it was created through a corporate spin-off. Its roots, however, go back much further through the development of SCA’s tissue, personal care, and professional hygiene businesses over many decades.

• Pre-2017: The businesses that became Essity were built inside SCA through organic growth and acquisitions across tissue, personal care, and professional hygiene.
• 2017: Essity became an independent public company. Around the same period, the acquisition of BSN medical materially expanded the company’s Health & Medical footprint.
• 2022: Essity acquired Knix, extending its presence in leakproof apparel and direct-to-consumer capabilities.
• 2024: Essity sold its majority stake in Vinda, a significant portfolio reshaping move that simplified the company and highlighted a sharper capital-allocation focus.

The broad historical arc is clear: a traditional hygiene-products portfolio has been gradually reshaped into a more diversified hygiene-and-health company with stronger emphasis on medical solutions, adult incontinence, and professional hygiene systems.

15. What Are the Key Suppliers to Essity?

Suppliers matter a great deal to Essity because the company’s cost base is heavily influenced by raw materials, energy, packaging, and logistics. Essity does not publicly disclose a comprehensive list of named suppliers in the way a small company might, but the critical supplier categories are clear.

Supplier structure matters strategically because Essity cannot rely on pricing alone to defend margins. Procurement scale, hedging, multi-sourcing, supplier quality, and sustainability qualification are all important parts of the model.

16. What Are the Key Brands Owned by Essity?

Brands are a major strategic asset for Essity, although their role differs by category. In consumer products and professional hygiene, branding is a primary competitive lever. In medical categories, brand still matters, but evidence, quality, and clinical trust matter just as much.

17. How Does the Supply Chain of Essity Function?

Essity’s supply chain is strategically important because it serves high-volume, high-frequency categories where service levels matter and many products are physically bulky relative to their unit value.

1. Sourcing and procurement. The company secures fiber, polymers, nonwovens, packaging, and energy through a global procurement base that must balance cost, quality, availability, and sustainability requirements.
2. Manufacturing network. Tissue and hygiene products are made and converted in regional manufacturing networks designed to limit freight intensity and support local customer service. Medical products add another layer of quality and regulatory control.
3. Inventory and warehousing. Essity needs enough inventory to maintain service levels across retail, healthcare, and distributor channels, but too much inventory can tie up cash and amplify raw-material risk.
4. Transportation and delivery. Outbound logistics are a meaningful cost lever, especially in tissue and professional hygiene products. Route optimization, warehouse placement, and on-time-in-full performance matter.
5. Channel replenishment. Retailers, distributors, hospitals, and professional customers all require different replenishment rhythms. That creates planning complexity but also a barrier to entry for smaller competitors.

Supply-chain reliability matters not just for cost control but also for customer trust, especially in healthcare and institutional hygiene where stockouts can have operational consequences for the customer.

18. What Are the Key Assets of Essity?

Essity is materially asset-intensive, even if it is not as capital-heavy as a miner or airline. Its key assets include:

• Manufacturing plants and converting sites for tissue, absorbent hygiene, and medical products.
• Global brands such as TENA, Tork, Leukoplast, JOBST, Libero, and Tempo.
• Product and materials know-how in absorbency, wound care, compression, and hygiene systems.
• Installed dispenser base in Professional Hygiene, which helps anchor recurring refill demand.
• Distribution relationships with retailers, jan-san distributors, pharmacies, and healthcare providers.
• R&D and innovation capabilities that support product performance and category expansion.
• Regulatory and quality systems that are particularly valuable in Health & Medical.

Asset intensity affects returns in two ways. It creates barriers to entry because building brands, factories, and distribution simultaneously is hard. But it also creates operating leverage, meaning profitability can move sharply when volumes, input costs, or utilization shift.

19. What Is the Technology Strategy of Essity?

Essity’s technology strategy appears to have two layers: technology as an internal operating enabler and technology as part of the customer offering.

Internally, technology supports automation, manufacturing efficiency, planning, quality control, and digital commerce. For a company with large raw-material exposure and a broad manufacturing footprint, process technology and data visibility are essential for yield, waste reduction, uptime, and working-capital control.

Externally, the clearest public example is Tork Vision Cleaning and related digital hygiene solutions. These offerings move Professional Hygiene beyond pure consumables and toward connected workflows, usage visibility, and smarter cleaning operations. That is strategically important because it raises switching costs and makes the value proposition more consultative.

Technology is therefore not the whole story at Essity, but it is increasingly central to competitiveness, especially where digital tools can support premium positioning, service differentiation, and industrial productivity.

20. What Is the R&D Strategy of Essity?

R&D is an important part of Essity’s strategy because product performance matters in nearly every one of its categories. The company needs to improve absorbency, fit, discretion, softness, strength, skin-friendliness, and clinical efficacy, often while lowering material use and environmental impact.

In Consumer Goods, R&D supports better-performing diapers, incontinence products, feminine care, and tissue products. In Health & Medical, R&D has a more technical role in wound care, compression, and orthopedic solutions. In Professional Hygiene, innovation spans dispenser design, refill efficiency, hygiene performance, and digital workflow solutions.

Essity’s R&D strategy appears to be applied and commercially oriented rather than purely exploratory. The goal is usually not breakthrough science for its own sake; it is differentiated product performance, material efficiency, customer relevance, and premiumization. That fits the economics of the business.

21. What Is the Finance Strategy of Essity?

Essity’s finance strategy, as reflected in FY2024 communication, is closely linked to profitability recovery, capital discipline, and portfolio quality. After the industry-wide inflation shock in raw materials and energy, restoring margins through pricing, mix, and cost actions became a central financial priority.

Cash generation matters because Essity runs a large manufacturing footprint and high-volume working-capital flows. Management therefore needs to balance inventory carefully, control capital expenditures, and protect balance-sheet flexibility while still funding innovation and selective growth investments.

The 2024 sale of the majority stake in Vinda was also a finance-strategy event, not just a portfolio event. It signaled a willingness to recycle capital out of less-core holdings and reinforce financial flexibility. More broadly, Essity’s capital allocation appears disciplined rather than aggressive: invest behind priority categories, maintain a sound balance sheet, support shareholder returns, and use acquisitions selectively where strategic fit is clear.

22. What Major Acquisitions Has Essity Made?

Essity does not appear to be a constant roll-up acquirer. Its M&A pattern has been more selective and strategic, aimed at capability building, category expansion, and portfolio improvement.

Just as important as these acquisitions was Essity’s later portfolio pruning. The 2024 disposal of the majority stake in Vinda showed that management is willing to use divestitures as well as acquisitions to sharpen strategic focus. That combination suggests M&A at Essity is best understood as portfolio shaping, not empire building.

23. How Companies Like Essity Leverage Independent Consultants through Umbrex

Umbrex has built a global community of more than 8,000 independent management consultants based in over 50 countries. These consultants are alumni of McKinsey, Bain, BCG, and other top firms. Companies like Essity use Umbrex when they want that caliber of problem-solving talent without hiring a full consulting team with all the overhead. For a hygiene and health company balancing brand building, manufacturing economics, portfolio reshaping, healthcare channel complexity, ERP, and AI, that flexible model can be particularly useful.

Representative projects Umbrex can support for a company like Essity include:

• Portfolio strategy review to assess where Essity should concentrate investment across Health & Medical, Consumer Goods, and Professional Hygiene.
• Pricing and revenue-growth-management redesign for retailer negotiations, distributor programs, and tender-driven healthcare channels.
• Procurement and should-cost analysis for pulp, fiber, superabsorbent polymer, nonwovens, packaging, and logistics spend.
• Manufacturing-footprint and network-optimization work to reduce freight intensity, improve plant utilization, and support service levels.
• Post-merger integration or carve-out support for bolt-on acquisitions, brand additions, or portfolio divestitures.
• Distributor and channel-strategy redesign for Tork and Health & Medical, including key-account coverage and partner economics.
• E-commerce and direct-to-consumer acceleration for brands such as TENA, Knix, and other sensitive-category products where digital education matters.
• Supply-chain planning and sales-and-operations-planning improvement to lower inventory while protecting availability.
• Sustainability program design covering packaging transitions, fiber sourcing, emissions roadmap economics, and customer-facing sustainability value propositions.
• AI, data, and ERP initiatives such as demand forecasting, pricing analytics, trade-spend optimization, predictive maintenance, and commercial dashboards.